These implants will further the Company's initiatives to increase the scale of our platform. POS revenue was $418,000 and $430,000 for the 90 days ended April 30, 2015 and 2014, respectively, a loss of $12,000 or 3 percent. Core income from our TumorGraft technology platform decreased $35,000 or 9 percent. This reduce is due to the cessation of implant activities inside our Singapore entity because of regulatory restrictions. Non-primary POS revenue elevated $24,000. POS income was $1.7 million and $2.3 million for the twelve months ended April 30, 2015 and 2014, respectively, a loss of $0.6 million or 27 percent.Glucocorticoids–including cortisone in human beings and corticosterone in mice–play many roles through the entire physical body, including metabolic response to starvation, antiinflammatory immune response, and the timing of circadian rhythms in peripheral organs. As a result, light-induced secretion of glucocorticoids may play an integral role in physiological adjustments in the body and the brain evoked by light, reported research author Hitoshi Okamura of Kobe University Graduate College of Medicine in Japan First presented in the early 1980s for the treatment of seasonal affective disorder, bright light therapy has been put on many sleep disorders, including jet lag syndrome and shift work sleep disorder, the reseachers said.